In the entire cohort of 172 patients with XLH, the information about genetic analysis was available for 147 patients among which 130 patients had a mutation in their PHEX gene (88%); in 17 patients (12%), we did not find a mutation. The gene discussed is PHEX; the disease is X-linked hypophosphatemia.